louisiana glp-1 gastroparesis class action Study Ties Diabetes, Weight Loss Drugs to Serious Digestive Issues Drug-Induced Gastroparesis and Product Liability
Description
Compare Metformin and Ozempic for weight loss in 2025
The FDA has granted accelerated approval of Wegovy (semaglutide) for adults with moderate to advanced metabolic dysfunction-associated steatohepatitis (MASH)
I never was able to get to the weight I needed to be no matter what I did, no matter how much I trained
This study aimed to determine whether prescription patterns across different cardiorenal phenotypic subgroups reflect clinical risk or are affected by demographic factors
95% CI 1.09 to 2.12
Learn 5 reasons including Metabolic Adaptation, Dosing Issues, Hormonal Resistance, and Lean Mass Loss.
